Zobrazeno 1 - 10
of 61
pro vyhledávání: '"Marko Sysi‐Aho"'
Autor:
Ann-Britt Marcher, Anne Loft, Ronni Nielsen, Terhi Vihervaara, Jesper Grud Skat Madsen, Marko Sysi-Aho, Kim Ekroos, Susanne Mandrup
Publikováno v:
Cell Reports, Vol 13, Iss 9, Pp 2000-2013 (2015)
Cold exposure greatly alters brown adipose tissue (BAT) gene expression and metabolism to increase thermogenic capacity. Here, we used RNA sequencing and mass-spectrometry-based lipidomics to provide a comprehensive resource describing the molecular
Externí odkaz:
https://doaj.org/article/e749a7d550da4a318785f7f55d4b5e07
Autor:
Janne Nikkilä, Marko Sysi‐Aho, Andrey Ermolov, Tuulikki Seppänen‐Laakso, Olli Simell, Samuel Kaski, Matej Orešič
Publikováno v:
Molecular Systems Biology, Vol 4, Iss 1, Pp 1-7 (2008)
Abstract Little is known about the human intra‐individual metabolic profile changes over an extended period of time. Here, we introduce a novel concept suggesting that children even at a very young age can be categorized in terms of metabolic state
Externí odkaz:
https://doaj.org/article/5d9e871e0446433c838e9a99754b94b9
Publikováno v:
PLoS ONE, Vol 7, Iss 12, p e51909 (2012)
Progression to type 1 diabetes is characterized by complex interactions of environmental, metabolic and immune system factors, involving both degenerative pathways leading to loss of pancreatic β-cells as well as protective pathways. The interplay b
Externí odkaz:
https://doaj.org/article/af53fb7f767746ff80bc2fcb7f1ee51e
Autor:
Marko Sysi-Aho, Andrey Ermolov, Peddinti V Gopalacharyulu, Abhishek Tripathi, Tuulikki Seppänen-Laakso, Johanna Maukonen, Ismo Mattila, Suvi T Ruohonen, Laura Vähätalo, Laxman Yetukuri, Taina Härkönen, Erno Lindfors, Janne Nikkilä, Jorma Ilonen, Olli Simell, Maria Saarela, Mikael Knip, Samuel Kaski, Eriika Savontaus, Matej Orešič
Publikováno v:
PLoS Computational Biology, Vol 7, Iss 10, p e1002257 (2011)
Recent evidence from serum metabolomics indicates that specific metabolic disturbances precede β-cell autoimmunity in humans and can be used to identify those children who subsequently progress to type 1 diabetes. The mechanisms behind these disturb
Externí odkaz:
https://doaj.org/article/efa2394923bf45da8529c7eec04cc069
Autor:
Marko Sysi-Aho, Juha Koikkalainen, Tuulikki Seppänen-Laakso, Maija Kaartinen, Johanna Kuusisto, Keijo Peuhkurinen, Satu Kärkkäinen, Margareta Antila, Kirsi Lauerma, Eeva Reissell, Raija Jurkko, Jyrki Lötjönen, Tiina Heliö, Matej Orešič
Publikováno v:
PLoS ONE, Vol 6, Iss 1, p e15744 (2011)
Dilated cardiomyopathy (DCM), characterized by left ventricular dilatation and systolic dysfunction, constitutes a significant cause for heart failure, sudden cardiac death or need for heart transplantation. Lamin A/C gene (LMNA) on chromosome 1p12 i
Externí odkaz:
https://doaj.org/article/268eb6061f0948ca9461ace159bd6b9f
Autor:
Kirsi H Pietiläinen, Marko Sysi-Aho, Aila Rissanen, Tuulikki Seppänen-Laakso, Hannele Yki-Järvinen, Jaakko Kaprio, Matej Oresic
Publikováno v:
PLoS ONE, Vol 2, Iss 2, p e218 (2007)
Both genetic and environmental factors are involved in the etiology of obesity and the associated lipid disturbances. We determined whether acquired obesity is associated with changes in global serum lipid profiles independent of genetic factors in y
Externí odkaz:
https://doaj.org/article/391d52eeadb94f528dd8805a23457cea
Autor:
Reijo Laaksonen, Mikko Katajamaa, Hannu Päivä, Marko Sysi-Aho, Lilli Saarinen, Päivi Junni, Dieter Lütjohann, Joél Smet, Rudy Van Coster, Tuulikki Seppänen-Laakso, Terho Lehtimäki, Juhani Soini, Matej Oresic
Publikováno v:
PLoS ONE, Vol 1, p e97 (2006)
BACKGROUND: Aggressive lipid lowering with high doses of statins increases the risk of statin-induced myopathy. However, the cellular mechanisms leading to muscle damage are not known and sensitive biomarkers are needed to identify patients at risk o
Externí odkaz:
https://doaj.org/article/73089aa923d2441d8757dd8ed15e155e
Autor:
Matej Orešič, Kristiina Iljin, Olli Kallioniemi, Tuulia Hyötyläinen, Cornelia Radke, Christiane Richter-Ehrenstein, Sibylle Loibl, Oliver Fiehn, Julian L. Griffin, Marko Sysi-Aho, Heli Nygren, Emilia Berg, Sandra Castillo, Laxman Yetukuri, Elmar Bucher, Jan Budczies, Tuulikki Seppänen-Laakso, Scarlet Brockmöller, Berit Müller, Laura Lehtinen, Carsten Denkert, Mika Hilvo
Supplementary Methods from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6405dcfa943b7fbbc2f19bf8db86570b
https://doi.org/10.1158/0008-5472.22393781.v1
https://doi.org/10.1158/0008-5472.22393781.v1
Autor:
Matej Orešič, Kristiina Iljin, Olli Kallioniemi, Tuulia Hyötyläinen, Cornelia Radke, Christiane Richter-Ehrenstein, Sibylle Loibl, Oliver Fiehn, Julian L. Griffin, Marko Sysi-Aho, Heli Nygren, Emilia Berg, Sandra Castillo, Laxman Yetukuri, Elmar Bucher, Jan Budczies, Tuulikki Seppänen-Laakso, Scarlet Brockmöller, Berit Müller, Laura Lehtinen, Carsten Denkert, Mika Hilvo
Supplementary Table 3 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::32a8d5e59e6f8f97a5a0f611a93cb893
https://doi.org/10.1158/0008-5472.22393769.v1
https://doi.org/10.1158/0008-5472.22393769.v1
Autor:
Matej Orešič, Kristiina Iljin, Olli Kallioniemi, Tuulia Hyötyläinen, Cornelia Radke, Christiane Richter-Ehrenstein, Sibylle Loibl, Oliver Fiehn, Julian L. Griffin, Marko Sysi-Aho, Heli Nygren, Emilia Berg, Sandra Castillo, Laxman Yetukuri, Elmar Bucher, Jan Budczies, Tuulikki Seppänen-Laakso, Scarlet Brockmöller, Berit Müller, Laura Lehtinen, Carsten Denkert, Mika Hilvo
Supplementary Table 9 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6249705cc0dd54b1670b1958efa3fe1e
https://doi.org/10.1158/0008-5472.22393751.v1
https://doi.org/10.1158/0008-5472.22393751.v1